NDC 69152-1114

Carcinosinum 200C

Carcinosinum

Carcinosinum 200C is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Paramesh Banerji Life Sciences Llc. The primary component is Human Breast Tumor Cell.

Product ID69152-1114_1862b88d-066c-5635-e054-00144ff88e88
NDC69152-1114
Product TypeHuman Otc Drug
Proprietary NameCarcinosinum 200C
Generic NameCarcinosinum
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2017-02-02
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameParamesh Banerji Life Sciences LLC
Substance NameHUMAN BREAST TUMOR CELL
Active Ingredient Strength200 [hp_C]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 69152-1114-1

96 PELLET in 1 BOTTLE (69152-1114-1)
Marketing Start Date2017-02-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69152-1114-1 [69152111401]

Carcinosinum 200C PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2017-02-02
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
HUMAN BREAST TUMOR CELL200 [hp_C]/1

OpenFDA Data

SPL SET ID:1862b88d-066b-5635-e054-00144ff88e88
Manufacturer
UNII

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.